AAAAAA

   
Results: 1-14 |
Results: 14
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC (R)) for Helicobacter pylori eradication
Authors: Agro, K Blackhouse, G Goeree, R Willan, AR Huang, JQ Hunt, RH O'Brien, BJ
Citation: K. Agro et al., Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC (R)) for Helicobacter pylori eradication, PHARMACOECO, 19(8), 2001, pp. 831-843
Economic implications of hip fracture: Health service use, institutional care and cost in Canada
Authors: Wiktorowicz, ME Goeree, R Papaioannou, A Adachi, JD Papadimitropoulos, E
Citation: Me. Wiktorowicz et al., Economic implications of hip fracture: Health service use, institutional care and cost in Canada, OSTEOPOR IN, 12(4), 2001, pp. 271-278
Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario
Authors: Goeree, R Jang, D Blackhouse, G Chong, S Mahony, J Sellors, J Foy, A Chernesky, M
Citation: R. Goeree et al., Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario, SEX TRA DIS, 28(12), 2001, pp. 701-709
Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator the - Canadian Implantable Defibrillator Study
Authors: Sheldon, R O'Brien, BJ Blackhouse, G Goeree, R Mitchell, B Klein, G Roberts, RS Gent, M Connolly, SJ
Citation: R. Sheldon et al., Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator the - Canadian Implantable Defibrillator Study, CIRCULATION, 104(14), 2001, pp. 1622-1626
Cost-effectiveness of the implantable cardioverter-defibrillator - Resultsfrom the Canadian Implantable Defibrillator Study (CIDS)
Authors: O'Brien, BJ Connolly, SJ Goeree, R Blackhouse, G Willan, A Yee, R Roberts, RS Gent, M
Citation: Bj. O'Brien et al., Cost-effectiveness of the implantable cardioverter-defibrillator - Resultsfrom the Canadian Implantable Defibrillator Study (CIDS), CIRCULATION, 103(10), 2001, pp. 1416-1421
Investigating extrathoracic metastatic disease in patients with apparentlyoperable lung cancer
Authors: Guyatt, GH Bethune, DCG Deslauriers, J Inculet, RI Lefcoe, MS Winton, TL Shamji, FM Todd, TRJ Walter, SD Cook, DJ Guyatt, GH Buckingham, LA Duchesne, JS Khan, H Troyan, SM Lefcoe, MS Bethune, DCG Bugden, C Yazer, M Deslauriers, J Bedard, P Carrier, G Ferland, S Fournier, B Miller, JD Bennett, WF McDonald, E Torbiak, RP Shamji, FM Marryatt, G Matzinger, FR Reid, KR Winton, TL Darling, GE Hendler, A Herman, S Johnston, MR Jones, DP Keresteci, M Keshavjee, S McKneally, MF Pearson, FG Pugash, R Bruce, R Rosgen, SM Steinhardt, M Todd, TRJ Inculet, RI Casson, AG Lefcoe, MS Malthaner, RA Clifton, J Evans, KG Finley, RJ Fradet, G Muller, NL Nelems, B Staples, C Guyatt, GH Cook, DJ Darling, GE Inculet, RI Johnston, MR Winton, TL O'Brien, B Goeree, R Griffith, LE Walter, SD Casson, AG Cook, DJ Deslauriers, J
Citation: Gh. Guyatt et al., Investigating extrathoracic metastatic disease in patients with apparentlyoperable lung cancer, ANN THORAC, 71(2), 2001, pp. 425-433
Systematic implementation of an advance directive program in nursing homes- A randomized controlled trial
Authors: Molloy, DW Guyatt, GH Russo, R Goeree, R O'Brien, BJ Bedard, M Willan, A Watson, J Patterson, C Harison, C Standish, T Strang, D Darzins, PJ Smith, S Dubois, S
Citation: Dw. Molloy et al., Systematic implementation of an advance directive program in nursing homes- A randomized controlled trial, J AM MED A, 283(11), 2000, pp. 1437-1444
Will the use of low-molecular-weight heparin (enoxaparin) in patients withacute coronary syndrome save costs in Canada?
Authors: O'Brien, BJ Willan, A Blackhouse, G Goeree, R Cohen, M Goodman, S
Citation: Bj. O'Brien et al., Will the use of low-molecular-weight heparin (enoxaparin) in patients withacute coronary syndrome save costs in Canada?, AM HEART J, 139(3), 2000, pp. 423-429
Economic evaluation of long term management strategies for erosive oesophagitis
Authors: Goeree, R O'Brien, B Hunt, R Blackhouse, G Willan, A Watson, J
Citation: R. Goeree et al., Economic evaluation of long term management strategies for erosive oesophagitis, PHARMACOECO, 16(6), 1999, pp. 679-697
Hospital selection for unit cost estimates in multicentre economic evaluations - Does the choice of hospitals make a difference?
Authors: Goeree, R Gafni, A Hannah, M Myhr, T Blackhouse, G
Citation: R. Goeree et al., Hospital selection for unit cost estimates in multicentre economic evaluations - Does the choice of hospitals make a difference?, PHARMACOECO, 15(6), 1999, pp. 561-572
The valuation of productivity costs due to premature mortality: A comparison of the human-capital and friction-cost methods for schizophrenia
Authors: Goeree, R O'Brien, BJ Blackhouse, G Agro, K Goering, P
Citation: R. Goeree et al., The valuation of productivity costs due to premature mortality: A comparison of the human-capital and friction-cost methods for schizophrenia, CAN J PSY, 44(5), 1999, pp. 455-463
The economic burden of schizophrenia in Canada
Authors: Goeree, R O'Brien, BJ Goering, P Blackhouse, G Agro, K Rhodes, A Watson, J
Citation: R. Goeree et al., The economic burden of schizophrenia in Canada, CAN J PSY, 44(5), 1999, pp. 464-472
Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis
Authors: O'Brien, B Levine, M Willan, A Goeree, R Haley, S Blackhouse, G Gent, M
Citation: B. O'Brien et al., Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis, ARCH IN MED, 159(19), 1999, pp. 2298-2304
Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada
Authors: O'Brien, BJ Goeree, R Hux, M Iskedjian, M Blackhouse, G Gagnon, M Gauthier, S
Citation: Bj. O'Brien et al., Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada, J AM GER SO, 47(5), 1999, pp. 570-578
Risultati: 1-14 |